SCHEMBL30733928

SCHEMBL30733928

O=C(c1cccc(Cl)c1)c1cccc2cccn12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.46
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOB P27338 1/20 0.40
ERCC5 P28715 1/20 0.40
FEN1 P39748 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
ALOX15 P16050 1/20 0.39
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30733965 0.81 PARP1 (0.46) PARP1L3MBTL1ALDH1A1MAPTMAOB
SCHEMBL30733922 0.81 POLB (0.46) PARP1MAPTSMN1; SMN2NPC1RAB9A
SCHEMBL30733925 0.81 POLB (0.57) PARP1ALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL6954262 0.79 SMN1; SMN2 (0.61) PARP1KDM4EALDH1A1MAPTCYP1A2
SCHEMBL27001657 0.78 THRA (0.42) KDM4EL3MBTL1ALDH1A1ERCC5FEN1
SCHEMBL27004448 0.77 ELANE (0.45) L3MBTL1ALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL29822671 0.77 ELANE (0.45) L3MBTL1ALDH1A1MAPTCYP1A2CYP2D6
SCHEMBL3173817 0.75 PARP1 (0.68) PARP1L3MBTL1ALDH1A1MAPTMAOB
SCHEMBL30733931 0.74 MEN1 (0.41) KDM4EALDH1A1MAPTHSD17B10NPC1
SCHEMBL6799716 0.74 PBRM1 (0.56) KDM4EL3MBTL1ALDH1A1MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF ZHEJIANG UNIVERSITY (CN) 2024-07-11 US disclosed
EP-4306522-A1 FUSED RING HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AND APPLICATION THEREOF Zhejiang University (CN) 2024-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228487-A1 FUSED HETEROCYCLIC COMPOUND AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND APPLICATION THEREOF TRPM2, TRPM8, TRPM7 PARP1 4355/4885KDM4E 3939/4885L3MBTL1 4876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.